Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
F1000Research|August 1, 2022
High-risk human-caused pathogen exposure events from 1975-2016David Manheim, Gregory LewisPatterns (New York, N.Y.)|October 25, 2023
Building less-flawed metrics: Understanding and creating better measurement and incentive systemsDavid ManheimF1000Research|January 28, 2021
Option-based guarantees to accelerate urgent, high-risk vaccines: a new market-shaping approachDavid Manheim, Derek FosterDisaster Medicine and Public Health Preparedness|October 22, 2020
The Structure of Tweets About Vaccine Safety Between Health Organizations, Experts, and the Public: Analyzing Risk Communication ConversationsDavid Manheim, Anat Gesser-EdelsburgRisk Analysis : an Official Publication of the Society for Risk Analysis|May 4, 2021
Exploring Risks of Human Challenge Trials For COVID-19David Manheim, Witold Wiȩcek, Virginia Schmit, et al.Rand Health Quarterly|December 19, 2025
Understanding the Theoretical Limits of AI-Enabled Pathogen Design: Insights from a Delphi StudyDavid Manheim, Adeline Williams, Casey Aveggio, et al.Expert Opinion on Drug Discovery|March 19, 2013
SiDMAP: a metabolomics approach to assess the effects of drug candidates on the dynamic properties of biochemical pathwaysGreg Maguire, Paul Lee, David Manheim, et al.Health Security|January 11, 2023
Managing the Transition to Widespread Metagenomic Monitoring: Policy Considerations for Future BiosurveillanceChelsea Liang, James Wagstaff, Noga Aharony, et al.Plos Computational Biology|March 4, 2021
Testing, tracing and isolation in compartmental modelsSimone Sturniolo, William Waites, Tim Colbourn, et al.Pageof 5